Aviv Clinics

Aviv Clinics stands apart in the longevity space because it has invested in actual published research. The clinic's unique hyperbaric oxygen therapy protocol has been studied in peer-reviewed settings, with findings related to telomere lengthening and senescent cell clearance that have attracted attention from the scientific community. The UHMS-accredited facility reflects serious commitment to safety and clinical standards, and the extensive experience with hyperbaric sessions provides genuine operational expertise. The 12-week program goes beyond HBOT alone, integrating cognitive training, nutrition guidance, and fitness programming for a more holistic approach. Results reported for specific conditions, particularly brain injury recovery and long COVID, are compelling and supported by a growing body of evidence. The primary considerations are cost and scope: at $36,000-$60,000, the investment is significant for a program centered primarily around one therapeutic modality. The 12-week commitment also requires substantial time. As a comprehensive longevity solution, the narrow focus means patients seeking broad-spectrum diagnostics, regenerative therapies, or multiple biohacking modalities will need to supplement Aviv with other providers. For patients specifically seeking evidence-backed HBOT with clinical rigor and published research behind it, Aviv offers a differentiated and credible option.